Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance—A Narrative Review
Journal of Fungi · 11.08.2026 · 12 (8) · 596
DOI: 10.3390/jof12080596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 11.08.2026. Verfasst von Pilar Rivas-Pinedo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Diagnostic Mycology Group, Department of Microbiology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asociación Colombiana de Infectología.
Abstract (Originalsprache)
Invasive fungal infections (IFIs) are associated with high morbidity and mortality, particularly in immunocompromised or critically ill patients and in those with complex comorbidities. Despite advances in mycological diagnosis and antifungal therapy, outcomes remain poor in a significant proportion of patients. In clinical practice, a poor response is often attributed to microbiological resistance. This interpretation may lead to empirical treatment escalation, combination therapy without a clear indication, increased toxicity, clinically relevant drug–drug interactions, and inefficient use of healthcare resources. However, therapeutic failure rarely results from a single mechanism. More often, it reflects the interaction among host vulnerability, pathogen characteristics, delayed, incomplete, or incorrect diagnosis, insufficient antifungal exposure, and inadequate source control. This narrative review presents a structured clinical approach to evaluating suboptimal responses in IFIs without attributing them solely to antifungal resistance. It examines cross-cutting determinants and specific patterns associated with invasive aspergillosis, invasive candidiasis and persistent candidemia, cryptococcal meningitis, mucormycosis, infections caused by rare filamentous fungi, and disseminated endemic mycoses. It also presents clinical algorithms, checklists, and potential quality indicators to distinguish true from apparent failure, identify modifiable factors, and support transparent clinical decision-making within antifungal stewardship programs. The proposed framework supports the assessment of non-response through systematic diagnostic and therapeutic reassessment, timely source control, and identification of modifiable gaps in care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical and Diagnostic Mycology Group, Department of Microbiology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
- One Health Research Group for Infectious Diseases, Keralty, Department of Internal Medicine, Clínica Colsanitas S.A., Clínica Sebastián de Belalcázar, Cali 760045, Colombia.
- Clinical Research and Education Group (GIEDCO), Clínica de Occidente, Cali 760035, Colombia.
ORCID-Profile: Pilar Rivas-Pinedo, José Millán Oñate Gutiérrez
Förderung
- Asociación Colombiana de Infectología
Zitieren
APA
Rivas-Pinedo, P., & Oñate Gutiérrez, J. M. (2026). Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance—A Narrative Review. Journal of Fungi, 12(8), 596. https://doi.org/10.3390/jof12080596
Vancouver
Rivas-Pinedo P, Oñate Gutiérrez JM. Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance—A Narrative Review. Journal of Fungi. 2026;12(8):596. doi:10.3390/jof12080596
BibTeX
@article{RivasPinedo2026,
author = {Rivas-Pinedo, Pilar and Oñate Gutiérrez, José Millán},
title = {Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance—A Narrative Review},
journal = {Journal of Fungi},
year = {2026},
volume = {12},
number = {8},
pages = {596},
doi = {10.3390/jof12080596}
}
EUVIMED